BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics... Dec 28
The nasal spray vaccination could generate double protection for vaccine recipients - Influenza and the novel Coronavirus ... Sep 11
-Advertisements-